HCA Healthcare reported revenues of $18.321 billion for the first quarter of 2025.

Net income attributable to the company was $1.610 billion, translating to $6.45 per diluted share. Adjusted EBITDA reached $3.733 billion, and cash flows from operating activities totaled $1.651 billion. Same facility admissions increased by 2.6 percent, while same facility equivalent admissions rose by 2.8 percent compared to the first quarter of 2024.

HCA-Led Trials Show AI-Powered Alerts Significantly Improve Antibiotic Selection in Hospitals

Two large NIH-funded clinical trials conducted across 92 HCA Healthcare hospitals found that computerized alerts tailored to patient data improved antibiotic selection by 35% for abdominal infections and 28% for skin and soft tissue infections. The system, developed with UC Irvine and Harvard Pilgrim Health Care Institute, uses real-time data from electronic health records to help physicians avoid unnecessary broad-spectrum antibiotics. The findings, published in *JAMA*, support broader adoption of data-driven stewardship tools to combat antibiotic resistance in U.S. hospitals.

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has been named on Fortune’s 2025 World’s Most Admired Companies list. HCA Healthcare is ranked first overall in its industry.

HCA Healthcare Appoints Monica Cintado as Senior Vice President of Development

HCA Healthcare announced the appointment of Monica Cintado as senior vice president of development. In her new role, Cintado will lead the company’s enterprise development strategy, overseeing mergers, acquisitions, divestitures, and strategic investments. She will also manage market analysis, partnerships, and real estate planning to support HCA Healthcare’s continued growth.

Cintado, who first joined HCA Healthcare in 1993 and returned in 2015, previously served as vice president of development and head of corporate development. She brings extensive experience in healthcare partnerships and acquisitions, including leadership roles at United Surgical Partners International. She holds degrees from Vanderbilt University and Rollins College.

She succeeds Joe Sowell, who is retiring after more than 15 years of service. Sowell played a key role in shaping HCA Healthcare’s corporate strategy and leading major transactions.

Based in Nashville, HCA Healthcare operates 190 hospitals and around 2,400 care sites across 20 U.S. states and the UK, and continues to innovate through its learning health system and large-scale clinical research.

HCA Healthcare Foundation Awards $1.84 Million Grant to United Way for Family Support Initiative

On March 25, 2025, HCA Healthcare announced that its foundation will award a $1.84 million grant to Mile High United Way to launch *United for Healthy Starts*, a national initiative aimed at improving health, social, and educational outcomes for families. Funded through the HCA Healthcare Foundation’s Healthier Tomorrow Fund, the program will begin in Denver and expand through partnerships with United Ways in Dallas, Miami, and Nashville.

The initiative will provide home visitation and tailored support services for families with young children, helping them access essential care and resources. By creating a national collaborative learning community, *United for Healthy Starts* also aims to form new nonprofit partnerships and foster scalable impact beyond the initial grant.

This announcement extends HCA Healthcare’s 30-year history of supporting United Way, with over $17 million contributed to date. The grant reflects HCA’s broader commitment to advancing community health in the areas it serves.

100 HCA Healthcare Hospitals Earn Healthgrades Patient Safety Excellence Award

HCA Healthcare, Inc. announced the completion of a $5.25 billion senior notes offering through its wholly owned subsidiary, HCA Inc. The offering includes notes with maturities ranging from 2028 to 2055, with fixed and floating interest rates. The proceeds will be used for general corporate purposes, including debt repayment. The notes are guaranteed by HCA Healthcare and are subject to covenants limiting certain financial activities. Additionally, in case of a change of control and ratings downgrade, noteholders have the right to require HCA to repurchase the notes at 101% of their principal value.

HCA Healthcare, Inc. announced a proposed public offering of senior notes through its wholly owned subsidiary, HCA Inc. The actual terms of the notes, including maturity, interest rate, and principal amount, will be determined based on market conditions at the time of pricing. The proceeds from the offering will be used for general corporate purposes, potentially including the repayment of existing or future credit facilities.

The offering is being conducted under an effective shelf registration statement filed with the SEC and is being managed by BofA Securities, Barclays Capital, Citigroup Global Markets, J.P. Morgan Securities, Mizuho Securities USA, and Wells Fargo Securities.

HCA emphasized that this press release does not constitute an offer to sell or solicit securities in any jurisdiction where such action would be unlawful. The company also included forward-looking statements about the expected use of proceeds, noting that actual outcomes may differ due to market risks and uncertainties. More details on potential risks are available in HCA’s latest SEC filings.

HCA Healthcare reported strong financial results for Q4 2024, with revenues totaling $18.285 billion, a 5.7% increase compared to Q4 2023. Net income attributable to the company was $1.438 billion, or $5.63 per diluted share, which includes an estimated $0.60 per share impact from Hurricanes Helene and Milton. Adjusted EBITDA was $3.712 billion, up from $3.618 billion in the prior year. Cash flows from operating activities were $2.559 billion, slightly lower than $2.674 billion in Q4 2023.

Same facility admissions increased 3.0%, and same facility revenue per equivalent admission rose 2.9% compared to the same quarter in 2023. Same facility inpatient surgeries grew 2.8%, while outpatient surgeries declined 1.3%. The hurricanes resulted in additional expenses and revenue losses estimated at $200 million for Q4 and $250 million for the year.

For the full year 2024, revenues reached $70.603 billion, up from $64.968 billion in 2023, and net income attributable to the company was $5.760 billion, or $22.00 per diluted share. Adjusted EBITDA for 2024 was $13.882 billion, compared to $12.726 billion in 2023.

The company repurchased 4.739 million shares in Q4 at a cost of $1.7 billion, with $764 million remaining under its authorization. HCA’s Board also approved a new $10 billion share repurchase program and declared a quarterly cash dividend of $0.72 per share, payable on March 31, 2025.

HCA’s facilities impacted by the hurricanes have resumed normal operations, and future dividends will depend on the company’s financial performance. The company remains focused on long-term growth and operational improvements.